Assignee
MAZE THERAPEUTICS INC
US·4 granted patents·11 pending applications·6 citations·filing 2021–2025
Top patents by PatentIndex Score
15 records- 0188US11814367B2Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·4 cites·41 claims
- 0286US11976067B2APOL1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2023·Granted May 7, 2024·2 cites·159 claims
- 0373US12344610B2APOL1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·20 claims
- 0469US12534453B2Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2023·Granted Jan 27, 2026·0 cites·36 claims
- 0568US2025282781A1Apol1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0663US2026098025A1Dimeric compounds as inhibitors of glycogen synthase 1 (gys1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0761US2025011773A1Compositions and methods for treating tdp-43 proteinopathyMAZE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0858US2026085034A1N-(benzhydryl)cycloalkylcarboxamide derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0958US2026021085A1Cycloalkyl carboxylic acid derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1058US2024199546A1Inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1158US2026055083A1Apol1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1253US2024093189A1Vectors comprising stuffer polynucleotide sequencesMAZE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1350US2024316038A1Apol1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1449US2023287409A1Compositions and methods for treating neurodegenerative diseasesMAZE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1548US2025320196A1Apol1 inhibitors and methods of uses thereofMAZE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MAZE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →